Relaxin increases ubiquitin-dependent degradation of fibronectin in vitro and ameliorates renal fibrosis in vivo

American Journal of Physiology - Renal Physiology

Volumn 285, Issue 1 54-1, 2003, Pages

  McDonald, Glenn A ^a   Sarkar, Pradip ^b   Rennke, Helmut ^b   Unemori, Elaine ^c   Kalluri, Raghu ^b   Sukhatme, Vikas P ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Bradley Pharmaceuticals Inc   (United States)

Author keywords

Fibrosis; Kidney; Protein degradation

Indexed keywords

CREATININE; FIBRONECTIN; PROTEIN; RELAXIN; SOMATOMEDIN; UBIQUITIN; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CREATININE BLOOD LEVEL; FIBROSING ALVEOLITIS; GLOMERULOSCLEROSIS; HISTOLOGY; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FIBROSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; PROTEINURIA; RAT; ANIMAL; CELL CULTURE; DISEASE MODEL; FIBROSIS; GENE EXPRESSION REGULATION; GENETICS; GLOMERULONEPHRITIS; METABOLISM; WISTAR KYOTO RAT;

ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FIBRONECTINS; FIBROSIS; GENE EXPRESSION REGULATION; GLOMERULONEPHRITIS; MALE; MICE; RATS; RATS, INBRED WKY; RELAXIN; RNA; UBIQUITIN;

EID: 0038721960     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00157.2002     Document Type: Article

References (44)

1. Abbate M, Kalluri R, Corna D, Yamaguchi N, McCluskey RT, Hudson BG, Andres G, Zoja C, and Remuzzi G. Experimental Goodpasture's syndrome in Wistar-Kyoto rats immunized with α3 chain of type IV collagen. Kidney Int 54: 1550-1561, 1998.
2. Akiyama SK, Nagata K, and Yamada KM. Cell surface receptors for extracellular matrix components. Biochim Biophys Acta 1031: 91-110, 1990.
3. Barnes VL, Musa J, Mitchell RJ, and Barnes JL. Expression of embryonic fibronectin isoform EIIIA parallels a-smooth muscle actin in maturing and diseased kidney. J Histochem Cytochem 47: 787-798, 1999.
4. Bell RJ, Eddie LW, Lester AR, Wood EC, Johnston PD, and Niall HD. Relaxin in human pregnancy serum measured with an homologous radioimmunoassay. Obstet Gynecol 69: 585-589, 1987.
5. Border WA and Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med 331: 1286-1292, 1994.
6. Border WA, Noble NA, and Ketteler M. TGF-β: a cytokine mediator of glomerulosclerosis and a target for therapeutic intervention. Kidney Int Suppl 49: S59-S61, 1995.
7. Chen Y, Le Caherec F, and Chuck SL. Calnexin and other factors that alter translocation affect the rapid binding of ubiquitin to apoB in the Sec61 complex. J Biol Chem 273: 11887-11894, 1998.
8. Chihal HJ and Espey LL. Utilization of the releaxed symphysis pubis of guinea pigs for clues to the mechanism of ovulation. Endocrinology 93: 1441-1445, 1973.
9. Cooper SM, Keyser AJ, Beaulieu AD, Ruoslahti E, Nimni ME, and Quismorio FP Jr. Increase in fibronectin in the deep dermis of involved skin in progressive systemic sclerosis. Arthritis Rheum 22: 983-987, 1979.
10. Crawford RJ, Hudson P, Shine J, Niall HD, Eddy RL, and Shows TB. Two human relaxin genes are on chromosome 9. EMBO J 3: 2341-2345, 1984.
11. Danielson LA, Sherwood OD, and Conrad KP. Relaxin is a potent renal vasodilator in conscious rats. J Clin Invest 103: 525-533, 1999.
12. El Nahas AM, Muchaneta-Kubara EC, Zhang G, Adam A, and Goumenos D. Phenotypic modulation of renal cells during experimental and clinical renal scarring. Kidney Int Suppl 54: S23-S27, 1996.
13. Fisher EA, Zhou M, Mitchell DM, Wu X, Omura S, Wang H, Goldberg AL, and Ginsberg HN. The degradation of apolipoprotein B100 is mediated by the ubiquitin-proteasome pathway and involves heat shock protein 70. J Biol Chem 272: 20427-20434, 1997.
14. Garber SL, Mirochnik Y, Brecklin CS, Unemori EN, Singh AK, Slobodskoy L, Grove BH, Arruda JA, and Dunea G. Relaxin decreases renal interstitial fibrosis and slows progression of renal disease. Kidney Int 59: 876-882, 2001.
15. Hershko A and Ciechanover A. The ubiquitin system for protein degradation. Annu Rev Biochem 61: 761-807, 1992.
16. Hynes RO. Fibronectins. New York: Springer-Verlag, 1990.
17. + exchanger isoform 3 in human colon adenocarcinoma cell line Caco-2. Protein kinase C-mediated inhibition of the exchanger. J Biol Chem 273: 8790-8798, 1998.
18. Kahsai TZ, Enders GC, Gunwar S, Brunmark C, Wieslander J, Kalluri R, Zhou J, Noelken ME, and Hudson BG. Seminiferous tubule basement membrane. Composition and organization of type IV collagen chains, and the linkage of α3(IV) and a5(IV) chains. J Biol Chem 272: 17023-17032, 1997.
19. Knebelmann B, Ananth S, Cohen HT, and Sukhatme VP. Transforming growth factor alpha is a target for the von Hippel-Lindau tumor suppressor. Cancer Res 58: 226-231, 1998.
20. Koya D, Jirousek MR, Lin YW, Ishii H, Kuboki K, and King GL. Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 100: 115-126, 1997.
21. Kuncio GS, Neilson EG, and Haverty T. Mechanisms of tubulointerstitial fibrosis. Kidney Int 39: 550-556, 1991.
22. Kunkel SL and Remick DG. Cytokines in Health and Disease. New York: Dekker, 1992, p. xii and 568.
23. Lamande SR, Chessler SD, Golub SB, Byers PH, Chan D, Cole WG, Sillence DO, and Bateman JF. Endoplasmic reticulum-mediated quality control of type I collagen production by cells from osteogenesis imperfecta patients with mutations in the pro al (I) chain carboxyl-terminal propeptide which impair subunit assembly. J Biol Chem 270: 8642-8649, 1995.
24. Meerovitch K, Wing S, and Goltzman D. Preproparathyroid hormone-related protein, a secreted peptide, is a substrate for the ubiquitin proteolytic system. J Biol Chem 272: 6706-6713, 1997.
25. Mimnaugh EG, Bonvini P, and Neckers L. The measurement of ubiquitin and ubiquitinated proteins. Electrophoresis 20: 418-428, 1999.
26. Molinari M and Helenius A. Chaperone selection during glycoprotein translocation into the endoplasmic reticulum. Science 288: 331-333, 2000.
27. Ohh M, Yauch RL, Lonergan KM, Whaley JM, Stemmer-Rachamimov AO, Louis DN, Gavin BJ, Kley N, Kaelin WG Jr, and Iliopoulos O. The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. Mol Cell 1: 959-968, 1998.
28. Pause A, Lee S, Worrell RA, Chen DY, Burgess WH, Linehan WM, and Klausner RD. The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. Proc Natl Acad Sci USA 94: 2156-2161, 1997.
29. Ruoslahti E. Fibronectin and its receptors. Annu Rev Biochem 57: 375-413, 1988.
30. Schwartz AL and Ciechanover A. The ubiquitin-proteasome pathway and pathogenesis of human diseases. Annu Rev Med 50: 57-74, 1999.
31. Scott DL, Wainwright AC, Walton KW, and Williamson N. Significance of fibronectin in rheumatoid arthritis and osteoarthrosis. Ann Rheum Dis 40: 142-153, 1981.
32. Sharma K and Ziyadeh FN. The emerging role of transforming growth factor-β in kidney diseases. Am JPhysiol Renal Fluid Electrolyte Physiol 266: F829-F842, 1994.
33. Sonmez H, Suer S, Karaarslan I, Baloglu H, and Kokoglu E. Tissue fibronectin levels of human prostatic cancer, as a tumor marker. Cancer Biochem Biophys 15: 107-110, 1995.
34. Tang WW, Feng L, Loskutoff DJ, and Wilson CB. Glomerular extracellular matrix accumulation in experimental anti-GBM Ab glomerulonephritis. Nephron 84: 40-48, 2000.
35. Tsiokas L, Arnould T, Zhu C, Kim E, Walz G, and Sukhatme VP. Specific association of the gene product of PKD2 with the TRPC1 channel. Proc Natl Acad Sci USA 96: 3934-3939, 1999.
36. Unemori EN and Amento EP. Relaxin modulates synthesis and secretion of procollagenase and collagen by human dermal fibroblasts. J Biol Chem 265: 10681-10685, 1990.
37. Unemori EN, Pickford LB, Salles AL, Piercy CE, Grove BH, Erikson ME, and Amento EP. Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo. J Clin Invest 98: 2739-2745, 1996.
38. Varga J, Rudnicka L, and Uitto J. Connective tissue alterations in systemic sclerosis. Clin Dermatol 12: 387-396, 1994.
39. Vecchi M and Carpenter G. Constitutive proteolysis of the ErbB-4 receptor tyrosine kinase by a unique, sequential mechanism. J Cell Biol 139: 995-1003, 1997.
40. Ward CL, Omura S, and Kopito RR. Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83: 121-127, 1995.
41. Wickner S, Maurizi MR, and Gottesman S. Posttranslational quality control: folding, refolding, and degrading proteins. Science 286: 1888-1893, 1999.
42. Yamada KM. Fibronectins: structure, functions and receptors. Curr Opin Cell Biol 1: 956-963, 1989.
43. Yuehong MA, D'Antona D, LaChapelle L, Ryu JS, and Guller S. Role of the proteasome in the regulation of fetal fibronectin secretion in human placenta. Ann NY Acad Sci 943: 340-351, 2001.
44. Zhu G, Nicolson AG, Cowley BD, Rosen S, and Sukhatme VP. In vivo adenovirus-mediated gene transfer into normal and cystic rat kidneys. Gene Ther 3: 298-304, 1996.